Summary

The European Parliament Approves the World's First Comprehensive AI Legislation

On March 13, 2024, during its plenary session, the European Parliament approved the Proposal for a Regulation of the European Parliament and of the Council Establishing Harmonised Rules on Artificial Intelligence (AI Act). This approval came after the AI Act was signed by the Committee of Permanent Representatives (Coreper) on February 2, 2024, and received backing from both the Internal Market (IMCO) and the Civil Liberties, Justice, and Home Affairs (LIBE) Committees on February 13, 2024.

The Parliament has stated that the AI Act is pending a final review by legal and linguistic experts and is anticipated to be officially passed before the current legislative term ends, utilizing the correction process known as the corrigendum procedure. Additionally, the AI Act requires formal approval from the Council of the European Union. The legislation will become fully enforceable 24 months after it takes effect, with the following exceptions:

  • Prohibitions on certain practices will be effective six months after enactment;
  • Implementation of codes of practice will start nine months after enactment;
  • Rules for general-purpose AI, including governance, will be implemented 12 months after enactment;
  • Requirements for high-risk systems will come into effect 36 months after enactment.

Click here to read the press release

Pierre Malvoisin

COO

Home

Discover our latest articles

View All Blog Posts
A data protection officer reviewing a DPIA clinical trials checklist on a laptop, with EU regulatory documents visible on the desk
June 15, 2026
Biotech & Healthtech
Data Protection Impact Assessment

DPIA Clinical Trials: How the EDPB Harmonised Template Reshapes Sponsor Obligations

The EDPB's 2026 harmonised DPIA template changes how sponsors conduct data protection impact assessments in clinical trials. Learn what it means for your programme.

June 11, 2026
Events
Data Governance
Data Privacy Enforcement
Health Data Warehouse

Vendor GDPR in Clinical Trials: What the IQVIA CNIL Ruling Changes for Sponsors and Healthtech Companies

On 26 May 2026 the CNIL fined IQVIA Operations France EUR 5 million for failures in its two authorised health data warehouses, LRX and EMR. The decision exposes weaknesses in CRO data protection practice that have direct consequences for every pharmaceutical sponsor relying on a CRO to process patient, prescription or trial data. This article unpacks the four areas of failure, explains why pseudonymisation no longer offers the cover many sponsors assume, and sets out a practical oversight checklist for sponsor data controllers.

February 9, 2026
AI
Biotech & Healthtech
Regulations & Guidelines
Healthcare

EU AI Act for Healthcare: What Life Sciences Companies Need to Know before August 2026

EU AI Act 2026 healthcare enforcement requires immediate compliance to avoid penalties.

FAQs

Our frequently questions

No items found.